Regulatory dendritic cells program B cells to differentiate into CD19 hiFcγIIbhi regulatory B cells through IFN-β and CD40L

Blood

Volumn 120, Issue 3, 2012, Pages 581-591

  Qian, Li ^a,b   Qian, Cheng ^a   Chen, Yongjian ^a   Bai, Yi ^a   Bao, Yan ^a   Lu, Liwei ^c   Cao, Xuetao ^a,d  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b YANGZHOU UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CD19 ANTIGEN; CD40 LIGAND; FC RECEPTOR IIB; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; LYMPH NODE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SPLEEN;

EID: 84864126038     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-08-377242     Document Type: Article

References (47)

1. LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood. 2008;112(5):1570-1580.
2. Lund FE, Randall TD. Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat Rev Immunol. 2010;10(4):236-247.
3. Pelletier N, McHeyzer-Williams LJ, Wong KA, Urich E, Fazilleau N, McHeyzer-Williams MG. Plasma cells negatively regulate the follicular helper T cell program. Nat Immunol. 2010;11(2): 1110-1118.
4. Mauri C, Blair PA. Regulatory B cells in autoimmunity: developments and controversies. Nat Rev Rheumatol. 2010;6(11):636-643.
5. Kelly-Scumpia KM, Scumpia PO, Weinstein JS, et al. B cells enhance early innate immune responses during bacterial sepsis. J Exp Med. 2011;208(8):1673- 1682.
6. Bao Y, Han Y, Chen Z, Xu S, Cao X. IFN-alpha-producing PDCA-1+ Siglec-H- B cells mediate innate immune defense by activating NK cells. Eur J Immunol. 2011;41(3):657-668.
7. Calderón-Gómez E, Lampropoulou V, Shen P, et al. Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitis. Eur J Immunol. 2011;41(6):1696-1708.
8. Buettner M, Pabst R, Bode U. Lymph node stromal cells strongly influence immune response suppression. Eur J Immunol. 2011;41(3):624-633.
9. Blair PA, Noreña LY, Flores-Borja F, et al. CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 2010;32(1):129-140.
10. Iwata Y, Matsushita T, Horikawa M, et al. Characterization of a rare IL-10-competent B-cell subset in man that parallels mouse regulatory B10 cells. Blood. 2011;117(2):530-541.
11. Rafei M, Hsieh J, Zehntner S, et al. A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B-cell population with immune suppressive properties. Nat Med. 2009;15(9):1038-1045.
12. Hikada M, Zouali M. Multistoried roles for B lymphocytes in autoimmunity. Nat Immunol. 2010; 11(12):1065-1068.
13. Bouaziz JD, Calbo S, Maho-Vaillant M, et al. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol. 2010;40(10):2686-2691.
14. Yang M, Sun L, Wang S, et al. Novel function of B cell-activating factor in the induction of IL-10- producing regulatory B cells. J Immunol. 2010; 184(7):3321-3325.
15. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol. 2007;7(1):19-30. (Pubitemid 46020824)
16. Wu L, Liu YJ. Development of dendritic-cell lineages. Immunity. 2007;26(6):741-750. (Pubitemid 46908964)
17. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol. 2007;7(8):610-621. (Pubitemid 47123548)
18. Pallotta MT, Orabona C, Volpi C, et al. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol. 2011;12(9):870-878.
19. Xia S, Guo Z, Xu X, Yi H, Wang Q, Cao X. Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance. Blood. 2008; 112(8):3175-3185.
20. Tang H, Guo Z, Zhang M, Wang J, Chen G, Cao X. Endothelial stroma programs hematopoietic stem cells to differentiate into regulatory dendritic cells through IL-10. Blood. 2006;108(4): 1189-1197. (Pubitemid 44232014)
21. Zhang M, Tang H, Guo Z, et al. Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat Immunol. 2004; 5(11):1124-1133. (Pubitemid 39549626)
22. Lund FE. Cytokine-producing B lymphocytes-key regulators of immunity. Curr Opin Immunol. 2008; 20(3):332-338.
23. Shaw J, Wang YH, Ito T, Arima K, Liu YJ. Plasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70. Blood. 2010;115(15): 3051-3057.
24. Qian C, Jiang X, An H, et al. TLR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to NK-cell activation. Blood. 2006;108(7):2307- 2315.
25. Qian C, An H, Yu Y, Liu S, Cao X. TLR agonists induce regulatory dendritic cells to recruit Th1 cells via preferential IP-10 secretion and inhibit Th1 proliferation. Blood. 2007;109(8):3308-3315. (Pubitemid 46572518)
26. Xu X, Guo Z, Jiang X, et al. Regulatory dendritic cells program generation of IL-4-producing alternative memory CD4 T cells with suppressive activity. Blood. 2011;117(4):1218-1227.
27. Xu J, Foy TM, Laman JD, et al. Mice deficient for the CD40 ligand. Immunity. 1994;1(5):423-431.
28. Zhang Y, Liu S, Liu J, et al. Immune complex/Ig negatively regulate TLR4-triggered inflammatory response in macrophages through FcgammaRIIb- dependent PGE2 production. J Immunol. 2009; 182(1):554-562.
29. Wykes M, MacPherson G. Dendritic cell-B-cell interaction: dendritic cells provide B cells with CD40-independent proliferation signals and CD40-dependent survival signals. Immunology. 2000;100(1):1-3. (Pubitemid 30242875)
30. Litinskiy MB, Nardelli B, Hilbert DM. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol. 2002; 3(9):822-829.
31. Smith KG, Clatworthy MR. FcgammaRIIB in auto-immunity and infection: evolutionary and therapeutic implications. Nat Rev Immunol. 2010; 10(5):328-343.
32. Johnson BA 3rd, Kahler DJ, Baban B, et al. B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase. Proc Natl Acad Sci U S A. 2010;107(23):10644-10648.
33. Mousavi SA, Sporstøl M, Fladeby C, Kjeken R, Barois N, Berg T. Receptor-mediated endocytosis of immune complexes in rat liver sinusoidal endothelial cells is mediated by FcgammaRIIb2. Hepatology. 2007;46(3):871-884. (Pubitemid 47436133)
34. Miles SA, Conrad SM, Alves RG, Jeronimo SM, Mosser DM. A role for IgG immune complexes during infection with the intracellular pathogen leishmania. J Exp Med. 2005;201(5):747-754. (Pubitemid 40395120)
35. Blair PA, Chavez-Rueda KA, Evans JG, et al. Selective targeting of B cells with agonistic anti- CD40 is an efficacious strategy for the generation of induced regulatory T2-Like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol. 2009;182(6):3492-3502.
36. Ding Q, Yeung M, Camirand G, et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest. 2011;121(9):3645-3656.
37. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B-cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 2008;28(5):639-650. (Pubitemid 351636247)
38. Vigorito E, Gambardella L, Colucci F, McAdam S, Turner M. Vav proteins regulate peripheral B-cell survival. Blood. 2005;106(7):2391-2398. (Pubitemid 41510812)
39. Watanabe R, Ishiura N, Nakashima H, et al. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol. 2010;184(9):4801-4809.
40. Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol. 2008;8(1):34-47.
41. Carter NA, Vasconcellos R, Rosser EC, et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T Cells. J Immunol. 2011;186(10):5569-5579.
42. Matsumoto M, Fujii Y, Baba A, Hikida M, Kurosaki T, Baba Y. The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production. Immunity. 2011;34(5):703-714.
43. Yen JH, Ganea D. Interferon beta induces mature dendritic cell apoptosis through caspase-11/ caspase-3 activation. Blood. 2009;114(7):1344-1354.
44. Yen JH, Kong W, Ganea D. IFN-beta inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9. J Immunol. 2010;184(7): 3478-3486.
45. Axtell RC, de Jong BA, Boniface K, et al. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med. 2010;16(4): 406-412.
46. Ramgolam VS, Sha Y, Marcus KL, et al. B cells as a therapeutic target for IFN-beta in relapsing-remitting multiple sclerosis. J Immunol. 2011; 186(7):4518-4526.
47. Zhang X, Deriaud E, Jiao X, Braun D, Leclerc C, Lo-Man R. Type I interferons protect neonates from acute inflammation through interleukin 10- producing B cells. J Exp Med. 2007;204(5):1107-1118. (Pubitemid 46798154)